David Goldstein

Summary

Affiliation: New South Wales
Country: Australia

Publications

  1. pmc The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer
    D Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, High Street, Randwick, New South Wales 2031, Australia
    Br J Cancer 106:61-9. 2012
  2. pmc Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer
    D Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, Barker Street, Randwick, New South Wales 2031, Australia
    Br J Cancer 97:464-71. 2007
  3. doi request reprint Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy
    Susanna B Park
    Prince of Wales Medical Research Institute, Barker Street, Randwick, Sydney, NSW 2031, Australia
    Brain 132:2712-23. 2009
  4. doi request reprint Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy
    Susanna B Park
    Prince of Wales Clinical School, Barker Street, Randwick, Sydney, NSW 2063, Australia
    Exp Neurol 227:120-7. 2011
  5. doi request reprint Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity
    Susanna B Park
    Prince of Wales Medical Research Institute, Barker St, Randwick, Sydney, New South Wales 2031
    J Clin Oncol 27:1243-9. 2009
  6. ncbi request reprint The experience of cancer-related fatigue and chronic fatigue syndrome: a qualitative and comparative study
    Barbara Bennett
    Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia
    J Pain Symptom Manage 34:126-35. 2007
  7. doi request reprint Impact of gemcitabine chemotherapy and 3-dimensional conformal radiation therapy/5-fluorouracil on quality of life of patients managed for pancreatic cancer
    Michala Short
    Discipline of Medical Radiation Sciences, University of Sydney, and Department of Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales, Australia
    Int J Radiat Oncol Biol Phys 85:157-62. 2013
  8. doi request reprint Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort study
    David Goldstein
    Prince of Wales Hospital, Randwick, Australia
    J Clin Oncol 30:1805-12. 2012
  9. ncbi request reprint Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacy
    Stephen Clarke
    Department of Medical Oncology, Royal Prince Alfred Hospital Sydney Cancer Centre, Sydney, Australia
    Clin Colorectal Cancer 6:578-82. 2007
  10. pmc If I am in the mood, I enjoy it: an exploration of cancer-related fatigue and sexual functioning in women with breast cancer
    Kate Webber
    Department of Medical Oncology, Prince of Wales Hospital, High Street, Randwick, New South Wales 2031, Australia
    Oncologist 16:1333-44. 2011

Detail Information

Publications17

  1. pmc The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer
    D Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, High Street, Randwick, New South Wales 2031, Australia
    Br J Cancer 106:61-9. 2012
    ....
  2. pmc Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer
    D Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, Barker Street, Randwick, New South Wales 2031, Australia
    Br J Cancer 97:464-71. 2007
    ..This approach to treatment of locally advanced pancreatic cancer is safe and promising, with good local control for a substantial proportion of patients, and merits testing in a randomised trial...
  3. doi request reprint Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy
    Susanna B Park
    Prince of Wales Medical Research Institute, Barker Street, Randwick, Sydney, NSW 2031, Australia
    Brain 132:2712-23. 2009
    ..05) than those left with mild or moderate neurotoxicity, suggesting that assessment of sensory excitability parameters may provide a sensitive biomarker of severity for oxaliplatin-induced neurotoxicity...
  4. doi request reprint Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy
    Susanna B Park
    Prince of Wales Clinical School, Barker Street, Randwick, Sydney, NSW 2063, Australia
    Exp Neurol 227:120-7. 2011
    ..Findings from the present series suggest that oxaliplatin affects nerve excitability through voltage-dependent mechanisms, with specific effects mediated through axonal Na(+) channel inactivation...
  5. doi request reprint Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity
    Susanna B Park
    Prince of Wales Medical Research Institute, Barker St, Randwick, Sydney, New South Wales 2031
    J Clin Oncol 27:1243-9. 2009
    ..Because the mechanism of oxaliplatin-induced neurotoxicity remains unclear, the present study investigated the potential of axonal excitability techniques in identifying pathophysiologic mechanisms and early markers of nerve dysfunction...
  6. ncbi request reprint The experience of cancer-related fatigue and chronic fatigue syndrome: a qualitative and comparative study
    Barbara Bennett
    Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia
    J Pain Symptom Manage 34:126-35. 2007
    ..Qualitatively, CRF appears closely related to CFS. These findings raise the emergent hypothesis of a conserved neurobehavioral symptom complex, which results from diverse triggering insults...
  7. doi request reprint Impact of gemcitabine chemotherapy and 3-dimensional conformal radiation therapy/5-fluorouracil on quality of life of patients managed for pancreatic cancer
    Michala Short
    Discipline of Medical Radiation Sciences, University of Sydney, and Department of Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales, Australia
    Int J Radiat Oncol Biol Phys 85:157-62. 2013
    ..To report quality of life (QOL) results for patients receiving chemoradiation therapy for pancreatic cancer...
  8. doi request reprint Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort study
    David Goldstein
    Prince of Wales Hospital, Randwick, Australia
    J Clin Oncol 30:1805-12. 2012
    ..Hence, relationships to cancer, surgery, and adjuvant therapy are unclear...
  9. ncbi request reprint Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacy
    Stephen Clarke
    Department of Medical Oncology, Royal Prince Alfred Hospital Sydney Cancer Centre, Sydney, Australia
    Clin Colorectal Cancer 6:578-82. 2007
    ..This analysis assesses the efficacy and safety of a modified FOLFOX (oxaliplatin/leucovorin [LV]/5-fluorouracil [5-FU]) regimen given with a low dose of LV...
  10. pmc If I am in the mood, I enjoy it: an exploration of cancer-related fatigue and sexual functioning in women with breast cancer
    Kate Webber
    Department of Medical Oncology, Prince of Wales Hospital, High Street, Randwick, New South Wales 2031, Australia
    Oncologist 16:1333-44. 2011
    ..The current paper describes sexual functioning (SF) and its relationship to CRF, mood disorder, and quality of life (QOL) over the first year after completion of adjuvant therapy...
  11. pmc Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study
    David Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia
    BMC Cancer 6:240. 2006
    ..We sought to examine the longitudinal relationships between fatigue and mood disorder in women treated with adjuvant therapy for early stage breast cancer...
  12. ncbi request reprint Oxaliplatin and axonal Na+ channel function in vivo
    Arun V Krishnan
    Institute of Neurological Sciences, Prince of Wales Hospital, Sydney, New South Wales, Australia
    Clin Cancer Res 12:4481-4. 2006
    ..The aim of the study was to investigate the pathophysiology of oxaliplatin-induced neurotoxicity using clinical nerve excitability techniques that provide information about axonal ion channel function...
  13. pmc A serious complication of selected internal radiation therapy: case report and literature review
    Katrin M Sjoquist
    Department of Medical Oncology, Prince of Wales Hospital, High Street, Randwick, NSW Australia
    Oncologist 15:830-5. 2010
    ..The characteristic endoscopic, radiologic, and histopathologic findings are illustrated and recommendations are reviewed with regard to the current literature...
  14. doi request reprint Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas
    David Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, Randwick, NSW, Australia
    Cancer Chemother Pharmacol 67:519-25. 2011
    ..Biliary tract cancers (BTC) have a poor prognosis, and there is no consensus on the best chemotherapy regimen. This study determined the response rate for fixed-dose-rate (FDR) gemcitabine combined with cisplatin...
  15. doi request reprint Reaching further with online education? The development of an effective online program in palliative oncology
    Bogda Koczwara
    Department of Medical Oncology, Flinders Medical Centre, Bedford Park, SA 5042, Australia
    J Cancer Educ 25:317-23. 2010
    ..Sixty-five (75%) respondents planned to review or change their practice as a result. The online program is effective in meeting learning needs of Australian health providers, reaching high numbers with high acceptability...
  16. ncbi request reprint Clinical supervision and education via videoconference: a feasibility project
    Kristina Xavier
    Department of Medical Oncology, Prince of Wales Hospital, Randwick, NSW, Australia
    J Telemed Telecare 13:206-9. 2007
    ..3 out of 10). With regard to telephone supervision, most (80%) were very or extremely satisfied. The feedback indicated that remote supervision was well received and that participants were keen to continue their involvement...
  17. pmc Primary pancreatic lymphoma--pancreatic tumours that are potentially curable without resection, a retrospective review of four cases
    Peter S Grimison
    Institute of Oncology, Prince of Wales Hospital, Sydney, Australia
    BMC Cancer 6:117. 2006
    ..Symptoms, imaging and tumour markers can mimic pancreatic adenocarcinoma, but they are much more amenable to treatment. Treatment for PPL remains controversial, particularly the role of surgical resection...